Vicebio was acquired by Sanofi for $1.6B
14 July 2025
14 July 2025
Total investments received (USD): N/A
Round value (USD): 1.6b
Round investors:
Sanofi Ventures
Company: Vicebio
Industry:
Biotech
Health services
Related deals
Draig Therapeutics raised £107m with Access Biotechnology (led), SV Health Investors, ICG, Canaan Partners, SR One, Sanofi Ventures, and Schroders Capital.
Investments
07 June 2025
CellCentric raised $120m in Series C funding led by RA Capital Management, joined by Forbion, Avego Bioscience Capital, and BrightEdge.
Investments
09 May 2025
Belgium
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Italy
Portugal
Spain